Hims & Hers Health, Inc.

For the period ended Mar 31, 2026. Filed May 11, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 11, 2026

HIMS$22.94-11.8%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Balance Sheets

(In Thousands, Except Share and Per Share Data)

	March 31, 2026	December 31, 2025
(Unaudited)
Assets
Current assets:
Cash and cash equivalents	$222,266	$228,616
Short-term available-for-sale investments	528,609	348,876
Receivables, net	149,620	32,149
Inventory	79,073	80,128
Prepaid expenses and other current assets	65,795	77,869
Total current assets	1,045,363	767,638
Long-term available-for-sale investments	—	351,263
Goodwill	342,838	278,325
Property, equipment, and software, net	333,845	311,930
Intangible assets, net	261,034	196,116
Operating lease right-of-use assets	144,247	137,046
Deferred tax assets, net	92,091	82,707
Other long-term assets	47,625	29,680
Total assets	$2,267,043	$2,154,705
Liabilities and stockholders' equity
Current liabilities:
Accounts payable	$306,865	$143,278
Accrued liabilities	90,743	78,518
Deferred revenue	165,132	127,160
Earn-out payable	40,096	46,986
Earn-out liabilities	10,362	3,646
Operating lease liabilities	5,579	4,843
Total current liabilities	618,777	404,431
Convertible senior notes, net	974,106	972,580
Operating lease liabilities	152,352	143,167
Earn-out payable	26,944	—
Earn-out liabilities	12,287	53,009
Deferred tax liabilities, net	23,511	28,856
Other long-term liabilities	12,899	11,734
Total liabilities	1,820,876	1,613,777
Commitments and contingencies (Note 14)
Stockholders' equity:
Common stock – Class A shares, par value $0.0001, 2,750,000,000 shares authorized and 222,326,117 and 218,867,898 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively; Class V shares, par value $0.0001, 10,000,000 shares authorized and 8,377,623 shares issued and outstanding as of March 31, 2026 and December 31, 2025	23	23
Additional paid-in capital	656,436	652,383
Accumulated other comprehensive (loss) income	(4,405)	2,294
Accumulated deficit	(205,887)	(113,772)
Total stockholders' equity	446,167	540,928
Total liabilities and stockholders' equity	$2,267,043	$2,154,705

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.